RT Journal Article
SR Electronic
T1 SARS-CoV-2 RNA concentrations in primary municipal sewage sludge as a leading indicator of COVID-19 outbreak dynamics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.19.20105999
DO 10.1101/2020.05.19.20105999
A1 Jordan Peccia
A1 Alessandro Zulli
A1 Doug E. Brackney
A1 Nathan D. Grubaugh
A1 Edward H. Kaplan
A1 Arnau Casanovas-Massana
A1 Albert I. Ko
A1 Amyn A. Malik
A1 Dennis Wang
A1 Mike Wang
A1 Joshua L. Warren
A1 Daniel M. Weinberger
A1 Saad B. Omer
YR 2020
UL http://medrxiv.org/content/early/2020/06/12/2020.05.19.20105999.abstract
AB We report a time course of SARS-CoV-2 RNA concentrations in primary sewage sludge during the Spring COVID-19 outbreak in a northeastern U.S. metropolitan area. SARS-CoV-2 RNA was detected in all environmental samples, and when adjusted for the time lag, the virus RNA concentrations tracked the COVID-19 epidemiological curve. SARS-CoV-2 RNA concentrations were a leading indicator of community infection ahead of compiled COVID-19 testing data and local hospital admissions. Decisions to implement or relax public health measures and restrictions require timely information on outbreak dynamics in a community.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study was not a clinical trial and did not utilize human subjects or material, nor identify subjects. The study not a prospective study and did not utilized any interventions. Thus IRB review was not required. Environmental samples were collected at a wastewater treatment facility (which does not require IRB) and then compared to COVID-19 case data that is deidentified and publically available from the Connecticut Department of Health (https://data.ct.gov/stories/s/COVID-19-data/wa3g-tfvc/). Originally we viewed this study as more biological and submitted to bioRxiv. They however responded that it has implications for public health and should be submitted to medRxiv.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This was an environmental study of SARS-CoV-2 RNA in wastewater. RNA concentrations were compared to COVID-19 test data. All testing data was de-identified and is publicly available or available upon request. The study does not deal with human subjects in any way, thus IRB approval is not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOnce published, data will be available on the COVID tracker website. https://covidtrackerct.com/